William Blair, the premier global boutique with expertise in investment banking, investment management, and private wealth management, has named managing directors John Ivey and B.T. Remmert as the ...
William Blair reaffirmed their market perform rating on shares of Viasat (NASDAQ:VSAT – Free Report) in a report published on Friday morning,RTT News reports. Several other equities analysts have also ...
William Blair cut shares of Sprinklr (NYSE:CXM – Free Report) from an outperform rating to a market perform rating in a report released on Friday morning, MarketBeat reports. Other research analysts ...
Despite the recent launch of congenital adrenal hyperplasia (CAH) drug Crenessity, Neurocrine Biosciences' disappointing ...
William Blair reiterated a Market Perform rating on CBOE Holdings (NYSE:CBOE), following the company's latest earnings report. CBOE Holdings reported an adjusted EPS of $2.10, falling short of both ...
William Blair reaffirmed a Market Perform rating on Kenvue Inc (NYSE:KVUE), a consumer health company with a market capitalization of $38.69 billion. According to InvestingPro data, the company ...
Axsome settles Auvelity patent litigation with Teva, delaying a generic launch until 2038. Analysts see growth potential with Symbravo's migraine approval.
Adding a new indication for the CAR T cell therapy could help BMS offset the loss-of-exclusivity headwinds it faces in the ...
Records were broken, trophies were raised high and tickets to the state swim meet were punched during Saturday’s Region 1 ...
Records were broken, trophies were raised high and tickets to the state swim meet were punched during Saturday’s Region 1 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback